Cyanobacterial microalgae phycocyanin and phycocyanobilin to beneficially inhibit the activity of the UDP-GDH enzyme while significantly increasing the absorption and circulation of curcumin
The present invention provides a method for inhibiting the UDP-GDH enzyme, which has in itself important beneficial implications, thus strongly enhancing the absorption and circulation of the natural drug curcumin, which in itself is poorly absorbed by the human organism. The method consists in blending curcumin with whole cyanobacterial algae, particularly Aphanizomenon flos aquae (but also Spirulina) or algal extracts concentrating or purifying the cyanobacterial molecules phycocyanin and phycocyanobilin. The method solves the significant problem of poor curcumin absorption through substances that also add their own nutritional and antioxidant activity to the mix.
